Osaka, Japan

Tsutomi Arimuba


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tsutomi Arimuba: Innovator in Carbohydrate Absorption Inhibition

Introduction

Tsutomi Arimuba is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of health and nutrition through his innovative inventions. His work primarily focuses on developing solutions to combat diabetes and obesity.

Latest Patents

Arimuba holds a patent for a carbohydrate absorption inhibitor and the method for manufacturing the same. This invention provides a carbohydrate absorption inhibitor derived from evening primrose seed, which is significantly effective in preventing and curing diabetes mellitus and preventing obesity. The effective component of this inhibitor is characterized as an alcohol extract of evening primrose seed, preferably a defatted version. The extraction process utilizes ethanol or a 70 to 85% (v/v) aqueous ethanol solution. Additionally, the invention highlights that the carbohydrate absorption inhibitor contains polyphenols derived from evening primrose seed, including substances such as gallic acid, ellagic acid, catechin, pentagalloylglucose, procyanidin, and proantocyanidin.

Career Highlights

Arimuba is associated with Oryza Oil & Fat Chemical Co., Ltd., where he continues to innovate in the field of health-related products. His work has garnered attention for its potential impact on public health, particularly in managing diabetes and obesity.

Collaborations

He has collaborated with notable coworkers, including Yotaro Konishi and Michio Aitani, who contribute to the research and development efforts within the company.

Conclusion

Tsutomi Arimuba's innovative work in carbohydrate absorption inhibition represents a significant advancement in health science. His contributions have the potential to improve the lives of many individuals struggling with diabetes and obesity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…